| Literature DB >> 34151769 |
Marco Invernizzi1,2, Alessandro de Sire3, Konstantinos Venetis4,5, Emanuele Cigna6, Stefano Carda7, Margherita Borg1, Carlo Cisari2, Nicola Fusco4,5.
Abstract
Breast cancer is the most common malignant tumor and the most prevalent cause of mortality in women. Advances in early diagnosis and more effective adjuvant therapies have improved the long-term survival of these patients. Pharmacotherapies and intrinsic tumor-related factors may lead to a wide spectrum of treatment-related disabling complications, such as breast cancer-related lymphedema, axillary web syndrome, persistent pain, bone loss, arthralgia, and fatigue. These conditions have a detrimental impact on the health-related quality of life of survivors. Here, we sought to provide a portrait of the role that rehabilitation plays in breast cancer survivors. Particular emphasis has been put in terms of recovering function, improving independence in activities of daily living, and reducing disability. This complex scenario requires a precision medicine approach to provide more effective decision-making and adequate treatment compliance. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.Entities:
Keywords: Breast cancer; axillary web syndrome; bone loss; breast cancer-related lymphedema; cancer-related fatigue; fatigue; lymphedema; pain; quality of life; rehabilitation
Mesh:
Year: 2022 PMID: 34151769 DOI: 10.2174/1871520621666210609095602
Source DB: PubMed Journal: Anticancer Agents Med Chem ISSN: 1871-5206 Impact factor: 2.505